SageView Advisory Group, LLC

Position in MRK — Merck & Co., Inc.

CIK 1914558 NEWPORT BEACH, CA

Position in MRK

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$3,244,625

+$439,342 QoQ

Shares Held

25,250

+8.3% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.44%

of 13F equity value

Holder Rank

#1,294

of 3,769 holders

Holding Since

Dec 2022

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

SageView Advisory Group, LLC holds $31,073,717 across 11 Drug Manufacturers - General names. MRK ranks #4 (10.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	11,047	$13,250,104
2	JNJ	Johnson & Johnson	19,763	$5,019,209
3	ABBV	AbbVie Inc.	16,291	$4,099,467
4	MRK	Merck & Co., Inc. This page	25,250	$3,244,625
5	AMGN	Amgen Inc	4,580	$1,658,509
6	PFE	Pfizer Inc	51,687	$1,244,622
7	GILD	Gilead Sciences, Inc.	8,588	$1,085,007
8	BMY	Bristol Myers Squibb Co	9,232	$531,947

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,244,625	25,250	+8.3%	Shares	Sole	2026-08-10
2026-03-31	$2,805,283	23,321	-43.9%	Shares	Sole	2026-08-10
2025-12-31	$4,376,605	41,579	-9.0%	Shares	Sole	2026-02-17
2025-09-30	$3,835,265	45,696	+95.2%	Shares	Sole	2025-11-13
2025-06-30	$1,853,214	23,411	+34.9%	Shares	Sole	2025-08-13
2025-03-31	$1,557,425	17,351	-28.8%	Shares	Sole	2025-05-19
2024-12-31	$2,422,636	24,353	+22.3%	Shares	Sole	2025-02-13
2024-09-30	$2,260,866	19,909	+10.3%	Shares	Sole	2024-11-14
2023-09-30	$1,858,144	18,049	-11.2%	Shares	Sole	2023-11-03
2023-06-30	$2,344,609	20,319	+4.6%	Shares	Sole	2023-08-11
2023-03-31	$2,065,987	19,419	+118.7%	Shares	Sole	2023-05-02
2022-12-31	$985,236	8,880	—	Shares	Sole	2023-02-15
No filing history on record for this holder in this stock.